| Literature DB >> 28090576 |
Elizabeth Mutter-Rottmayer1, Yanzhe Gao2, Cyrus Vaziri2.
Abstract
Trans-lesion synthesis (TLS) is a DNA damage-tolerant and error-prone mode of DNA replication. Recent work shows that many cancer cells coopt an aberrantly expressed germ cell protein, melanoma antigen-A4 (MAGE-A4), to activate TLS. MAGE-A4-induced "pathological TLS" provides a potential mechanism through which neoplastic cells can tolerate intrinsic and therapeutic genotoxicity while acquiring mutability.Entities:
Keywords: Cancer-testes antigens (CTA); DNA damage; RAD18; genome maintenance; melanoma antigen-A4 (MAGE-A4); mutagenesis; trans-lesion synthesis (TLS)
Year: 2016 PMID: 28090576 PMCID: PMC5160398 DOI: 10.1080/23723556.2016.1225547
Source DB: PubMed Journal: Mol Cell Oncol ISSN: 2372-3556